Tachycardia Clinical Trials

116 recruitingLast updated: June 18, 2026

There are 116 actively recruiting tachycardia clinical trials across 45 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4, Early Phase 1. Top locations include Nashville, Tennessee, United States, Rochester, Minnesota, United States, Calgary, Alberta, Canada. Updated daily from ClinicalTrials.gov.


Tachycardia Trials at a Glance

116 actively recruiting trials for tachycardia are listed on ClinicalTrialsFinder across 6 cities in 45 countries. The largest study group is Not Applicable with 56 trials, with the heaviest enrollment activity in Nashville, Rochester, and Calgary. Lead sponsors running tachycardia studies include Vanderbilt University Medical Center, University of Calgary, and IRCCS Ospedale San Raffaele.

Browse tachycardia trials by phase

Treatments under study

About Tachycardia Clinical Trials

Looking for clinical trials for Tachycardia? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Tachycardia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Tachycardia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 116 trials

Recruiting
Not Applicable

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

Ventricular Tachycardia (VT)
Medtronic Cardiac Ablation Solutions60 enrolled6 locationsNCT06703489
Recruiting

Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Atrial FibrillationAtrial FlutterAtrial Arrhythmia+1 more
Tulane University50 enrolled3 locationsNCT05014802
Recruiting

Complex Arrhythmia Registry

Atrial Fibrillation (AF)Ventricular Tachycardia (VT)
Beijing Anzhen Hospital4,000 enrolled2 locationsNCT07024927
Recruiting
Phase 1

A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

Catecholaminergic Polymorphic Ventricular Tachycardia
Solid Biosciences Inc.18 enrolled5 locationsNCT07148089
Recruiting
Not Applicable

Localization of Anatomical Structures Involved in Nodal Tachycardias by High Density Mapping.

Atrioventricular Nodal Reentry TachycardiaSupraventricular Tachycardia
University Hospital, Toulouse20 enrolled1 locationNCT05296954
Recruiting
Not Applicable

International Multicenter Project Comparing Radiofrequency Ablation Versus Implantable Defibrillator After Well-tolerated Ventricular Tachycardia in Ischemic Heart Disease With Minimally Impaired Ejection Fraction

Ventricular TachycardiaIschemic Heart Disease
University Hospital, Toulouse268 enrolled1 locationNCT06294028
Recruiting
Phase 4

Adenosine vs Diltiazem for Treatment of SVT in the ED

Supraventricular Tachycardia (SVT)
Anne E. Zepeski20 enrolled1 locationNCT06993038
Recruiting

PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency Department

Supraventricular Tachycardia (SVT)
University of Iowa20 enrolled1 locationNCT07086560
Recruiting
Not Applicable

NASVAL-SVT: Nasal Swab Versus Modified Valsalva for Supraventricular Tachycardia

Atrioventricular Nodal Reentry TachycardiaSupraventricular TachycardiaParoxysmal Supraventricular Tachycardia+1 more
Marmara University Pendik Training and Research Hospital60 enrolled1 locationNCT07617077
Recruiting

Evolution of Intracardiac Electrograms Recorded by Left Bundle Branch Pacing Lead in Patients With ICD or CRT-D

Ventricular FibrillationVentricular Tachycardia (VT)
Medtronic Cardiac Rhythm and Heart Failure50 enrolled2 locationsNCT06745778
Recruiting

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Heart FailureArrhythmiaBradycardia+1 more
Medtronic20,000 enrolled320 locationsNCT00271180
Recruiting

National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry

Sudden Cardiac DeathArrhythmogenic Right Ventricular DysplasiaCardiomyopathy, Dilated+11 more
Hospital do Coracao1,211 enrolled27 locationsNCT06546137
Recruiting
Not Applicable

CAlgary SAlt for POTS

Postural Orthostatic tachycardia Syndrome
University of Calgary50 enrolled1 locationNCT05924646
Recruiting
Not Applicable

Compression Garments in the Community With POTS

Postural Orthostatic tachycardia Syndrome
University of Calgary30 enrolled1 locationNCT04881318
Recruiting

Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies

Atrial FibrillationVentricular TachycardiaPremature Ventricular Contraction
Vanderbilt University Medical Center200 enrolled1 locationNCT06575881
Recruiting
Not Applicable

NC Testing in LC & POTS

Postural Orthostatic tachycardia SyndromePost-acute Sequelae of SARS-CoV-2 Infection
University of Calgary100 enrolled1 locationNCT05914649
Recruiting
Not Applicable

Hypercapnia and Orthostatic Tolerance in Postural Orthostatic Tachycardia Syndrome

Orthostatic intolerancePostural Tachycardia Syndrome
University of Calgary26 enrolled1 locationNCT04271878
Recruiting

POTS Adrenergic Ab (CIHR Aims #1&2)

Postural Tachycardia Syndrome
University of Calgary125 enrolled1 locationNCT02673996
Recruiting

Cardiac RadiothErapy for VEntricular Tachycardia II

Ventricular Tachycardia (VT)
Universitaire Ziekenhuizen KU Leuven50 enrolled1 locationNCT06744530
Recruiting
Not Applicable

Ablation of Consecutive Atrial Tachycardia

Arrhythmias, CardiacHeart DiseasesAtrial Tachycardia+1 more
Evangelical Hospital Düsseldorf100 enrolled6 locationsNCT05239364